共 50 条
- [1] Phase 1b/3 Pharmacokinetics and Safety Study of Intravenous Posaconazole in Adult Asian Participants at High Risk for Invasive Fungal InfectionsADVANCES IN THERAPY, 2022, 39 (04) : 1697 - 1710Wu, DepeiMi, YingchangWeng, JianyuZhuang, JunlingKe, XiaoyanWang, ChunLiu, KaiyanMartinho, MonikaWinchell, Gregory A.Zang, YanqiaoXu, Lianzhe
- [2] Phase 1B Study of the Pharmacokinetics and Safety of Posaconazole Intravenous Solution in Patients at Risk for Invasive Fungal DiseaseANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 3610 - 3617Maertens, JohanCornely, Oliver A.Ullmann, Andrew J.Heinz, Werner J.Krishna, GopalPatino, HernandoCaceres, MariaKartsonis, NicholasWaskin, HettyRobertson, Michael N.
- [3] Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with NeutropeniaANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (10) : 5758 - 5765Duarte, Rafael F.Lopez-Jimenez, JavierCornely, Oliver A.Laverdiere, MichelHelfgott, DavidHaider, ShariqChandrasekar, PranatharthiLangston, AmeliaPerfect, JohnMa, Leivan Iersel, Marlou L. P. S.Connelly, NancyKartsonis, NicholasWaskin, Hetty
- [4] Pharmacokinetics and Safety of Posaconazole Tablet Formulation in Chinese Participants at High Risk for Invasive Fungal InfectionAdvances in Therapy, 2020, 37 : 2493 - 2506Kaiyan LiuDepei WuJunmin LiHu ChenHongmei NingTing ZhaoHaiping DaiLi ChenEric ManginGregory A. WinchellHetty WaskinJun JiangYanping QiuXu Min Zhao
- [5] Pharmacokinetics and Safety of Posaconazole Tablet Formulation in Chinese Participants at High Risk for Invasive Fungal InfectionADVANCES IN THERAPY, 2020, 37 (05) : 2493 - 2506Liu, KaiyanWu, DepeiLi, JunminChen, HuNing, HongmeiZhao, TingDai, HaipingChen, LiMangin, EricWinchell, Gregory A.Waskin, HettyJiang, JunQiu, YanpingZhao, Xu Min
- [6] Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal diseaseJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (03) : 718 - 726Cornely, Oliver A.Duarte, Rafael F.Haider, ShariqChandrasekar, PranatharthiHelfgott, DavidLopez Jimenez, JavierCandoni, AnnaRaad, IssamLaverdiere, MichelLangston, AmeliaKartsonis, NicholasVan Iersel, MarlouConnelly, NancyWaskin, Hetty
- [7] Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infectionsANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) : 632 - 638Benjamin, DKDriscoll, TSeibel, NLGonzalez, CERoden, MMKilaru, RClark, KDowell, JASchranz, JWalsh, TJ
- [8] Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease (vol 71, pg 718, 2016)JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (06) : 1747 - 1747Cornely, Oliver A.Duarte, Rafael F.Haider, ShariqChandrasekar, PranatharthiHelfgott, DavidJimenez, Javier LopezCandoni, AnnaRaad, IssamLaverdiere, MichelLangston, AmeliaKartsonis, NicholasVan Iersel, MarlouConnelly, NancyWaskin, Hetty
- [9] Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease (vol 72, pg 3406, 2017)JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (12) : 3501 - 3501Cornely, Oliver A.Robertson, Michael N.Haider, ShariqGrigg, AndrewGeddes, MichelleAoun, MickaelHeinz, Werner J.Raad, IssamSchanz, UrsMeyer, Ralf G.Hammond, Sarah P.Mullane, Kathleen M.Ostermann, HelmutUllmann, Andrew J.Zimmerli, StefanVan Iersel, M. L. P. S.Hepler, Deborah A.Waskin, HettyKartsonis, Nicholas A.Maertens, Johan
- [10] Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignanciesINTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 (03) : 384 - 388Hachem, RayAssaf, AndrewNuman, YazanShah, PankilJiang, YingChaftari, Anne-MarieRaad, Issam I.